BaselineWatch
60913 CVEs · 136 in KEV
Desk
CVEs known60,913 New, 24 h97 Changed, 24 h100 In KEV136 Public exploit1,650 Match watchlist0

Vulnerabilities

All My stack Known exploited Public exploit Critical (9+) Likely exploited (EPSS ≥ 50%) Changed, 24 h New, 24 h Sort: risk modified published CVSS EPSS
CVEs
CVECVSSEPSSVendor, productDescriptionModified
CVE-2026-61320 8.8 high 0.00% oracle, e-business_suite Vulnerability in the Oracle Payables product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.8-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Payables. Successful attacks of this vulnerability can result in takeover of Oracle Payables. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H). 24 Oct
CVE-2026-70701 8.1 high 0.00% oracle, payables Vulnerability in the Oracle Payables product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Payables. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Payables accessible data as well as unauthorized access to critical data or complete access to all Oracle Payables accessible data. CVSS 3.1 Base Score 8.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N). 22 Oct
CVE-2026-61087 7.5 high 0.00% oracle, peoplesoft_enterprise_fin_payables Vulnerability in the PeopleSoft Enterprise FIN Payables product of Oracle PeopleSoft (component: Security). The supported version that is affected is 9.2. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise PeopleSoft Enterprise FIN Payables. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all PeopleSoft Enterprise FIN Payables accessible data. CVSS 3.1 Base Score 7.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N). 24 Oct
CVE-2026-70700 7.5 high 0.00% oracle, payables Vulnerability in the Oracle Payables product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Payables. Successful attacks of this vulnerability can result in unauthorized ability to cause a hang or frequently repeatable crash (complete DOS) of Oracle Payables. CVSS 3.1 Base Score 7.5 (Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H). 22 Oct
CVE-2025-61762 6.3 medium 0.00% oracle, peoplesoft_enterprise_fin_payables Vulnerability in the PeopleSoft Enterprise FIN Payables product of Oracle PeopleSoft (component: Payables). The supported version that is affected is 9.2. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise PeopleSoft Enterprise FIN Payables. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of PeopleSoft Enterprise FIN Payables accessible data as well as unauthorized read access to a subset of PeopleSoft Enterprise FIN Payables accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of PeopleSoft Enterprise FIN Payables. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L). 8 Oct

5 of 5

Download these 5 as CSV · subscribe to this list.

EPSS scores: 2026-10-31. NVD cursor: 2026-10-29 00:22. The News page shows only notable CVEs (KEV, your stack, new criticals, EPSS over 50%, or active exploitation per SSVC); this table has all of them.